Sanofi and GSK plan to ask regulators to authorize their COVID-19 vaccine
(WASHINGTON) -- Drugmakers Sanofi and GlaxoSmithKline announced Wednesday they are planning to ask regulators to authorize their new COVID-19 vaccine candidate.The companies said data shows the shot works either as a primary vaccine, with 100% effectiveness against severe disease and hospitalization, or as a...
